Economic evaluation of percutaneous cryoablation vs conventional surgery in extra-abdominal desmoid tumours in the Spanish healthcare system.

"Declarations Ethics approval and consent to participateThis analysis required the access to patient data at the hospital level related to APR-DRG codification. The Clinical Research Ethics Committee of the Bellvitge University Hospital reviewed and approved the protocol for access to APR-DRG. Patient consent to participate was not required. Consent for publicationNot applicable. Competing interestsThis analysis was developed with unrestricted financial support from Boston Scientific. IO and NT are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consultant company specialising in health technology assessment, which has received financial support from Boston Scientific to conduct the development of the present work. JAN, DB and RGM declare proctoring in cryoablation for Boston Scientific. The remaining authors declare that they have no competing interests. Competing interests This analysis was developed with unrestricted financial support from Boston Scientific. IO and NT are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consultant company specialising in health technology assessment, which has received financial support from Boston Scientific to conduct the development of the present work. JAN, DB and RGM declare proctoring in cryoablation for Boston Scientific. The remaining authors declare that they have no competing interests."

"Declarations: Ethics approval and consent to participateThis analysis required the access to patient data at the hospital level related to APR-DRG codification. The Clinical Research Ethics Committee of the Bellvitge University Hospital reviewed and approved the protocol for access to APR-DRG. Patient consent to participate was not required.: Consent for publicationNot applicable.: Competing interestsThis analysis was developed with unrestricted financial support from Boston Scientific. IO and NT are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consultant company specialising in health technology assessment, which has received financial support from Boston Scientific to conduct the development of the present work. JAN, DB and RGM declare proctoring in cryoablation for Boston Scientific. The remaining authors declare that they have no competing interests. Competing interests: This analysis was developed with unrestricted financial support from Boston Scientific. IO and NT are employees of Pharmacoeconomics & Outcomes Research Iberia (PORIB), a consultant company specialising in health technology assessment, which has received financial support from Boston Scientific to conduct the development of the present work. JAN, DB and RGM declare proctoring in cryoablation for Boston Scientific. The remaining authors declare that they have no competing interests."